Spiros Linardopoulos

3.9k citations
71 papers · 2.5k indexed · h-index 28
    • Microtubule and mitosis dynamics 40
  • Oncology top 2%
    • Cancer-related Molecular Pathways 33
    • PARP inhibition in cancer therapy 4
    • Protein Degradation and Inhibitors 10
    • Ubiquitin and proteasome pathways 8
    • Epigenetics and DNA Methylation 6
  • Hematology top 5%
    • Acute Myeloid Leukemia Research 6
    • Neuroblastoma Research and Treatments 5

Spiros Linardopoulos

71 papers receiving 2.5k citations

Peers

Spiros Linardopoulos
Comparison fields: 5 of 92
  • Cell Biology 1.1k
  • Oncology 1.1k
  • Molecular Biology 1.7k
  • Cancer Research 337
  • Hematology 192
Replace Lyubomir T. Vassilev with:
Lyubomir T. Vassilev United States
Julian M.C. Golec United States
Anke Baum Austria
Jeffrey Ecsedy United States
Richele K. Rasmussen Australia
Nicholas Kwiatkowski United States
Mathias Schmidt Germany
Jens Quant Austria
Gerhard Siemeister Germany
Mohammed M. Dar United States
Spiros Linardopoulos relative to Lyubomir T. Vassilev United States Lyubomir T. Vassilev's profile →
Citations per field
00.5×1.5×2.1×
Lyubomir T. Vassilev · 1×
Citations per year

Countries citing papers authored by Spiros Linardopoulos

Since Specialization
Citations

This map shows the geographic impact of Spiros Linardopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spiros Linardopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spiros Linardopoulos more than expected).

Fields of papers citing papers by Spiros Linardopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spiros Linardopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spiros Linardopoulos. The network helps show where Spiros Linardopoulos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Spiros Linardopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Spiros Linardopoulos Line = papers co-authored together Spiros Linardopoulos links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20233
2 202112
3 202020
4 20194
5 201740
6 201524
7 201464
8 20135
9 201167
10 201027
11 201051
12 200785
13 200766
14 200754
15 20068
16 200660
17 2003267
18 200079
19 19952
20 199310

About Spiros Linardopoulos

Spiros Linardopoulos is a scholar working on Cell Biology, Oncology and Hematology, having authored 71 papers that have together received 2.5k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (40 papers), Cancer-related Molecular Pathways (33 papers), Protein Degradation and Inhibitors (10 papers), Ubiquitin and proteasome pathways (8 papers), Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (6 papers), Neuroblastoma Research and Treatments (5 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Cell Biology (1.1k citations), Oncology (1.1k citations) and Molecular Biology (1.7k citations). Spiros Linardopoulos has collaborated with scholars based in United Kingdom, Greece and United States. Frequent co-authors include Vassilios Bavetsias, Florence Chan, Paraskevi Briassouli, Allan Balmain, Paul Workman, Chongbo Sun, Julian Blagg, Giuseppe Portella, Paolo Chieffi and Silvana Libertini. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026